跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMISIL terbinafine 125mg (as hydrochloride) tablet - TGA Drug Approval Details
Approvals
/
TGA
/
LAMISIL terbinafine 125mg (as hydrochloride) tablet
Approved
STANDARD
LAMISIL terbinafine 125mg (as hydrochloride) tablet
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
55ea3849ea904d2a
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
55ea3849ea904d2a
Product Name
LAMISIL terbinafine 125mg (as hydrochloride) tablet
Artg Id
43522
Artg Name
LAMISIL terbinafine 125mg (as hydrochloride) tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1993-09-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/d6def53408c630a73659973a5dc802b5.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
55ea3849ea904d2a
Type
Standard
Back to TGA Approvals
